Lab
Laboratorio Clinico Marbella, INC
Laboratorio Clinico Marbella, INC was paid $684K by Medicaid between Jan 2018 and Dec 2024, across 41 billing codes. Its largest line is 86328, — 14% of everything it billed.
33Billing provider infoLABORATORIO CLINICO MARBELLA, INC
VEGA BAJA, PR 00693
VEGA BAJA, PR 00693
33aNPI1558593467assigned 08/12/2009
33bProvider typeClinical Medical Laboratory
28Total paid$684K
24GClaims57,981
24DCodes billed41
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Puerto Rico
Rank by total paid#190 of 777
Median peer was paid$278K
This provider vs. median2.5×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 6,239 | $58K | |
| 2019 | 5,723 | $49K | |
| 2020 | 9,774 | $104K | |
| 2021 | 12,275 | $167K | |
| 2022 | 10,318 | $156K | |
| 2023 | 7,456 | $81K | |
| 2024incomplete | 6,196 | $70K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 86328 | 14% | 3,570 | 3,267 | $93K | |
| 84443 | Thyroid stimulating hormone (TSH) | 12% | 5,321 | 5,131 | $83K |
| 80061 | Lipid panel | 9.5% | 5,146 | 4,954 | $65K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 9.4% | 2,675 | 2,431 | $64K |
| 80053 | Comprehensive metabolic panel | 8.3% | 5,842 | 5,498 | $57K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 7.7% | 7,243 | 6,713 | $52K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 7.6% | 1,897 | 1,840 | $52K |
| 83036 | Hemoglobin; glycosylated (A1C) | 3.8% | 2,826 | 2,726 | $26K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 3.3% | 463 | 429 | $22K |
| 36415 | Collection of venous blood by venipuncture | 3.1% | 5,373 | 4,956 | $21K |
| 81001 | 2.8% | 6,048 | 5,789 | $19K | |
| 82274 | 2.7% | 1,207 | 1,168 | $18K |
29 more codes
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 2.6% | 449 | $18K |
| 86738 | 2.1% | 1,120 | $15K | |
| 87275 | 1.6% | 889 | $11K | |
| 87276 | 1.6% | 876 | $11K | |
| 82043 | <1% | 1,110 | $7K | |
| 85027 | <1% | 994 | $6K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 720 | $5K |
| 84439 | <1% | 545 | $5K | |
| 87088 | <1% | 642 | $5K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 133 | $4K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 144 | $4K |
| 86701 | <1% | 363 | $3K | |
| 84153 | <1% | 161 | $3K | |
| 84436 | <1% | 382 | $2K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 269 | $2K |
| 84479 | <1% | 302 | $2K | |
| 82570 | <1% | 359 | $2K | |
| 82607 | <1% | 74 | $1K | |
| 86592 | <1% | 239 | $962.15 | |
| 86803 | <1% | 63 | $866.22 | |
| 86703 | <1% | 67 | $799.36 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 52 | $673.50 |
| 86790 | <1% | 31 | $435.24 | |
| 86696 | <1% | 12 | $345.87 | |
| 86695 | <1% | 12 | $236.46 | |
| 85651 | <1% | 69 | $226.83 | |
| 86038 | <1% | 12 | $137.38 | |
| 84155 | <1% | 85 | $84.77 | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 196 | $0.13 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialORTIZ-FRANCESCHI, NITZA (PRESIDENT)